If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Barclays Lifts FTSE's Lenders

Fri, 23rd Oct 2020 10:46

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Barclays up 6.2%. The lender kicked off the UK banking reporting season with a "resilient" performance in the third quarter of 2020. Barclays said pretax profit for the three months ended September came in at GBP1.15 billion, up sharply from GBP246 million a year earlier. Third-quarter group income declined 6% to GBP5.20 billion from GBP5.54 billion, however. Other FTSE 100 lenders rose in a positive read-across. StanChart climbed 4.7%, Lloyds was up 4.4%, HSBC rose 3.8% and NatWest was up 3.3%. They all report third-quarter results next week.

----------

FTSE 250 - LOSERS

----------

Airtel Africa down 4.5%. The Africa-focused mobile operator halved its interim dividend to 1.5 US cents from 3 cents a year earlier. Revenue in the first half of 2020 increased by 11% to USD1.82 billion from USD1.65 billion a year ago, with second-quarter revenue growth of 14%. Reported operating profit for the half year was USD472 million, up 20% year-on-year.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Pendragon, up 21%. The motor retailer is piling on more gains after surging 23% on Thursday. It had said Thursday that underlying pretax profit for the three months to ended September was GBP27.3 million, up sharply from GBP3.0 million from a year earlier.

----------

Goco Group up 6.3%. The price comparison site said revenue in the nine months ended September is up 13% annually at GBP130.5 million. Customers at its AutoSave Live arm have more than doubled to 597 from 241 a year earlier.

----------

Evgen Pharma, up 16%. The clinical stage drug development firm has landed all regulatory approvals for the STAR trial of its SFX-01 treatment. The drug is used to treat acute respiratory infections. Recruitment for the trial will begin at the end of October.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Avingtrans PLC, down 7.4%. Shareholder Nigel Wray sold 3.2 million shares in the company at 250 pence each, landing GBP8.1 million. Wray no longer has a stake in the company, which provides systems and services to the energy and industrial sectors.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
23 Nov 2020 17:37

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial

Read more
23 Nov 2020 12:22

Evgen doses first patients in 'STAR' respiratory trial

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Monday that the first patient had now been enrolled and dosed in the 'STAR' trial of its 'SFX-01' treatment for acute respiratory infections.

Read more
11 Nov 2020 15:53

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment

Read more
23 Oct 2020 11:49

Evgen gets full approval for SFX-01 trial in Covid-19 patients

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Friday that all necessary regulatory approvals had now been received for the 'STAR' trial of SFX-01 treatment for Acute Respiratory Infections.

Read more
23 Oct 2020 11:31

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial

Read more
24 Sep 2020 18:12

UK EXECUTIVE CHANGE SUMMARY: Carr's Names Pelham To Replace CEO Davies

UK EXECUTIVE CHANGE SUMMARY: Carr's Names Pelham To Replace CEO Davies

Read more
15 Sep 2020 22:08

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

Read more
15 Sep 2020 08:41

Evgen Pharma licences technology to Juvenescence

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the licensing of its sulforaphane stabilisation technology in a number of non-pharmaceutical applications to Juvenescence on Tuesday.

Read more
9 Jul 2020 16:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
17 Jun 2020 12:01

Evgen's 'SFX-01' to be tested with Covid-19 patients

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced its participation in the recently-notified funding initiative for Covid-19 clinical trials by the medical research charity LifeArc on Wednesday.

Read more
17 Jun 2020 10:42

Evgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial

Evgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial

Read more
15 Jun 2020 11:09

UK WINNERS & LOSERS SUMMARY: Bunzl Rises As It Sees Strong First Half

UK WINNERS & LOSERS SUMMARY: Bunzl Rises As It Sees Strong First Half

Read more
15 Jun 2020 10:24

Evgen Pharma Loss Slightly Wider On Expenses And Compensation

Evgen Pharma Loss Slightly Wider On Expenses And Compensation

Read more
15 Jun 2020 09:51

Losses widen as Evgen Pharma develops SFX-01

(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported a slight widening of its post-tax loss in its final results on Monday, to £2.7m, from £2.6m in the prior year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.